Food and Drug Administration (FDA), the approved dosages for some of the commonly prescribed GLP-1 agonists are as follows: Semaglutide (Ozempic): 0.5 mg, 1 mg, or 2 mg once weekly for type 2 diabetes, and up to 2.4 mg once weekly for chronic weight management (marketed as Wegovy)
Some patients benefit from a small daily maintenance fiber dose (and, in some cases, polyethylene glycol) to remain regular while on therapy., When is constipation a medical concern
Do I Qualify for Bariatric Surgery
Medication for IIH with acetazolamide, topiramate and/or furosemide was continued independently of the treatment with GLP-1-RAs
Prescribers advise halting use two months pre-conception, aligning with UK NICE guidelines for fertility planning
Beginning in April 2026, Medicare will also cover GLP-1 medications for beneficiaries with obesity and qualifying comorbidities